Showing results (2271-2280 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|April 3, 2020
An Open-Label Study of the Safety and Efficacy of Tag-7 Gene-Modified Tumor Cells-Based Vaccine in Patients with Locally Advanced or Metastatic Malignant Melanoma or Renal Cell CancerAleksei Viktorovich Novik, Anna Borisovna Danilova, Maksim Ivanovich Sluzhev, et al.
The Oncologist|September 21, 2020
Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3Hope S Rugo, Jens Huober, José A García-Sáenz, et al.
The Oncologist|September 1, 2020
Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future PerspectivesAri J Rosenberg, Everett E Vokes
The Oncologist|September 24, 2020
Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular CarcinomaLi-Ju Chen, Yun-Jau Chang, Yao-Jen Chang
The Oncologist|October 1, 2020
Acquired MET D1228N Mutations Mediate Crizotinib Resistance in Lung Adenocarcinoma with ROS1 Fusion: A Case ReportYu Wang, Zheng Chen, Xiao Han, et al.
The Oncologist|October 3, 2020
Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter StudyMichael Frass, Peter Lechleitner, Christa Gründling, et al.
The Oncologist|December 15, 2020
Current Status of Advance Care Planning and End-of-life Communication for Patients with Advanced and Metastatic Breast CancerYasuaki Sagara, Masanori Mori, Sena Yamamoto, et al.
The Oncologist|January 4, 2021
Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine TumorsClarisse Dromain, Arturo Loaiza-Bonilla, Beloo Mirakhur, et al.
The Oncologist|January 5, 2021
New Verse for a Familiar Song: Small Molecule Inhibitors for MET exon 14 Skipping Non-Small Cell Lung CancerXiuning Le, John V Heymach
The Oncologist|January 5, 2021
Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment-Related Adverse Events From the CheckMate 040 StudyKaren Julien, Hiu Tung Leung, Carmen Fuertes, et al.
Pageof 571